Gbs Inc GBS:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.7447quote price arrow up+0.0055 (+0.74%)
Volume
105,943
52 week range
0.38 - 5.11
Loading...
  • Open0.717
  • Day High0.7861
  • Day Low0.7101
  • Prev Close0.7392
  • 52 Week High5.11
  • 52 Week High Date07/14/21
  • 52 Week Low0.38
  • 52 Week Low Date02/23/22

Key Stats

  • Market Cap11.09M
  • Shares Out14.89M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-48.1

KEY STATS

  • Open0.717
  • Day High0.7861
  • Day Low0.7101
  • Prev Close0.7392
  • 52 Week High5.11
  • 52 Week High Date07/14/21
  • 52 Week Low0.38
  • 52 Week Low Date02/23/22
  • Market Cap11.09M
  • Shares Out14.89M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-48.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.49
  • P/E (TTM)-1.51
  • Fwd P/E (NTM)-4.14
  • EBITDA (TTM)-7.101M
  • ROE (TTM)-57.40%
  • Revenue (TTM)1.98M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-358.74%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gbs Inc

There is no recent news for this security.

Profile

MORE
GBS Inc. is a biosensor diagnostic technology company operating across the Asia-Pacific Region (APAC). The Company’s offers various products, including Biosensor Platform Technology, Saliva Glucose Test (SGT) and Saliva Glucose Biosensor (SGB). The Biosensor Platform is an Organic Thin Film Transistor (OTFT) architecture. The basis OTFT structure consists of a source and drain electrode, a semiconducting layer, a gate electrode, an optional separation or dielectric layer, all...
Stephen Boyages Ph.D.
Independent Chairman of the Board
Harry Simeonidis
President, Chief Executive Officer, Director
Spiro Sakiris
Chief Financial Officer
Address
733 Third Avenue
New York, NY
10017
United States